The Trump Administration will explore new payment models for prescription drugs at the Center for Medicare and Medicaid Innovation (CMMI) as part of a plan to redirect the focus of the reimbursement laboratory.
Drug Payment Experiments Coming To Medicare, Medicaid
Centers For Medicare and Medicaid Services releases 'request for information' on how to approach development of new payment models for prescription drugs in government-sponsored insurance.
